Alto Neuroscience, Inc. (NYSE:ANRO) Receives Average Recommendation of “Moderate Buy” from Brokerages
Alto Neuroscience, Inc. (NYSE:ANRO – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seven brokerages that are currently covering the company, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price […]
Alto Neuroscience, Inc. (NYSE:ANRO – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seven brokerages that are currently covering the company, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price […]
